Early research leads to positive outlook for patients with aggressive triple-negative breast cancer

Brenda Berchtold drives six hours to Baltimore every three weeks from Erie, Pa., to keep her standing as medical marvel.

First diagnosed with hard-to-cure “triple-negative” breast cancer in 1986 that returned and spread, Berchtold has been in remission since trying an experimental immune therapy at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.

Read the rest of this great article at the Baltimore Sun


Leave a Reply

Solve : *
28 + 29 =